PCI Pharma Services ("PCI") – a leading global contract development and manufacturing organization (CDMO) focused on ...

Acquisition creates a world-class large-scale manufacturing hub in San Diego region with state-of-the-art aseptic facilities ...

PCI Pharma Services is acquiring an entire equity stake in Ajinomoto Althea Inc. (Althea), a U.S.-based sterile fill-finish ...

the acquisition provides PCI with its first-ever North American manufacturing location for prefilled syringes and cartridges – including isolator technology for these formats – as well as high ...

The global intradermal injection market size is expected to surpass an impressive valuation of USD 3,878 Million in 2022 and is projected to exhibit a compound annual growth rate (CAGR) of 10.8% from ...

SAE Media Group's 15th Annual Pre-Filled Syringes and Injectable Drug Devices ... Sustainability for Injectable Delivery Devices Primary Packaging Development Connected Drug Delivery Devices ...

Drug Delivery Solutions Market Analysis The UK's aging population drives demand for advanced drug delivery systems to manage chronic, age-r ...

As Europe’s leading Pre-Filled Syringes conference, the 2020 event will assess innovations in device engineering and components, enhancement of human factors, and optimizing packaging and ...

This market research report provides an in-depth analysis of the Injectable Drug Delivery Market, projecting significant growth from 2025 to 2035. The global market is expected to expand from USD 704.

Novo Nordisk has said it is discontinuing selling its popular, best-selling insulin brand in India and will instead promote ...